Telmisartan 40 mg + Hydrochlorothiazide 12.5 mg Tablets

Maintain healthy blood pressure levels with this synergistic combination of Telmisartan (40 mg) and Hydrochlorothiazide (12.5 mg). Designed for oral administration, this film-coated formulation works by relaxing blood vessels and eliminating excess fluid to support comprehensive heart and kidney wellness. Comes in a secure Alu-Alu blister packaging containing 10 strips of 10 tablets each (100 tablets total). Please use as directed by a healthcare professional.

Telmisartan 40 mg + Hydrochlorothiazide 12.5 mg Tablets is a combination antihypertensive medication containing Telmisartan, an angiotensin II receptor blocker (ARB), and Hydrochlorothiazide, a thiazide diuretic. It is primarily prescribed for the management of high blood pressure (hypertension) when treatment with a single medicine does not provide adequate blood pressure control. Telmisartan works by blocking the action of angiotensin II, a substance that causes blood vessels to narrow, thereby helping blood vessels relax and reducing blood pressure. Hydrochlorothiazide helps the body eliminate excess sodium and water through urine, which reduces fluid volume and further supports blood pressure reduction. The combination of these two active ingredients provides complementary effects that can help achieve more effective blood pressure management and may reduce the risk of complications associated with uncontrolled hypertension, such as stroke, heart attack, and kidney damage. The 40 mg + 12.5 mg strength combines both medicines in a single tablet, supporting convenient treatment as prescribed by a healthcare professional. Possible side effects include dizziness, increased urination, dehydration, and changes in blood electrolyte levels. Regular monitoring of blood pressure, kidney function, and electrolytes may be necessary during treatment. This medicine should be used under medical supervision, with particular caution in patients with kidney or liver problems, and it must not be used during pregnancy because Telmisartan can harm the developing fetus.